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Abstract P718 – Table 1. Description of studies comparing South Asians and Caucasian incidence in ulcerative colitis and Crohn’s disease
sessment of the studies was performed by examining the number of
studies which fulfilled the following criteria: use of recognised diag-
nostic criteria, self-reporting of ethnic background and whether the
study was population based. The p-value from the test of heterogene-
ity is given, with the I2 value. Size of difference between both groups
is reported as a rate ratio, along with corresponding confidence inter-
vals. This is quantified as the incidence in SA relative to the incidence
in Caucasians.
Results: Eight studies met the inclusion criteria for Crohn’s disease
(CD) and Ulcerative Colitis (UC), seven in the UK and one study
in Canada (Table 1). The total population was 2,569,074. The UC
incidence was higher in SA in 3/4 studies with a rate ratio of UC 1.39
(0.84, 2.32) whereas CD incidence was lower in 5/6 CD studies with
a rate ratio of 0.78 (0.22, 2.78) compared with Caucasians (Table
2). There was significant heterogeneity between both UC and CD
studies. (I2 – 83%, p<0.001 and I2 – 95%, p<0.001).
Table 2. Summary statistic of incidence studies showing rate ratio of South
Asians to Caucasians
Conclusions: There is a lack of good quality recent data in the liter-
ature. One UC study reported a lower incidence rate (Jayanthi) but
only studied the Bangladeshi subgroup of the SA population whereas
the others reported on a predominantly North Indian population.
This finding suggests a difference in the presentation of IBD within
the SA population. One study showed a higher incidence of CD in SA
group than Caucasians which included a paediatric population. Early
environmental influences may be more important for the pathogen-
esis of CD than UC. We conclude that SA migrants have increased
risk of developing UC potentially due to exposure to new environ-
mental factors in the adopted country. Larger prospective population
based studies are needed to support these findings including differ-
ences between first and second generation migrants to implicate the
environmental exposure.
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Background: Tobacco consumption is an important environmental
factor in inflammatory bowel diseases (IBD). Our aim was to identi-
fied characteristics associated with smoking in Crohn’s disease (CD)
and Ulcerative colitis (UC).
Methods: Adult UC and CD patients included in the Swiss IBD co-
hort study (SIBDCS) from Nov. 2006 to Nov. 2015 were asked about
their smoking status. Patients were separated in two groups (active
smokers vs. non-smokers). A logistic regression analysis was per-
formed with smoking as main outcome.
Results: 999 UC and 1386 CD patients were included in the study.
In the univariate analysis, smoking was positively associated with
the female gender in CD patients. Smoking CD patients had more
stenosis and used significantly more oral Budesonide, whereas UC
patients used more topical treatments. A high anxiety and depression
score was significantly associated with smoking among CD patients.
The use of invalidity insurance was significantly higher in smoking
UC and CD patients in the univariate analysis and was confirmed in
the multivariate analysis (OR 1.8 [1.1–3.0], p=0.02 for UC and OR
3.4 [1.3–9.1], p=0.015 for CD).
Conclusions: After adjustment for disease pattern and activity, the
only factor significantly associated with tobacco consumption in IBD
patients is the need for invalidity insurance.
This positive association between active smoking and invalidity in-
surance is, however, not specific to IBD patients but also known in
the Swiss population
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